<

 
Data updated 2025-10-31 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date15896367.8 (espacenet)  (Federated)  (European Patent Register), 20150626
Patent/reg. no. and dateDK/EP 3315128, 20210519
Publication date20180502
Priority no. and date
EP pub. no. and date EP 3315128 20180502
Effective date
Applicant/ownerShionogi & Co., Ltd., 1-8, Doshomachi 3-chome
Chuo-ku
Osaka 541-0045, JP
Applicant ref. no.1602651
InventorKIYONO, Yuji, c/o Tokyo Head Office
Kissei Pharmaceutical Co. Ltd.
3-1-3 Koishikawa
Bunkyo-ku
Tokyo 112-0002, JP,
SHIMIZU, Yoshitaka, c/o Tokyo Head Office
Kissei Pharmaceutical Co. Ltd.
3-1-3 Koishikawa
Bunkyo-ku
Tokyo 112-0002, JP,
YAMANO, Hitoshi, c/o Tokyo Head Office
Kissei Pharmaceutical Co. Ltd.
3-1-3 Koishikawa
Bunkyo-ku
Tokyo 112-0002, JP,
IJIRO, Tomoyuki, c/o Central Research Laboratories
Kissei Pharmaceutical Co. Ltd.
4365-1 Hotaka-Kashiwabara
Azumino-shi
Nagano 399-8304, JP
RepresentativeRWS Group, RWS Compass House Vanwall Business Park, Vanwall Road Maidenhead, Berkshire SL6 4UB, GB
Opponent
IPC ClassA61K 31/427 (2006.01) , A61P 25/00 (2006.01) 
TitleDOSERINGSREGIME FOR ROVATIRELIN MOD ATAKSI I FORBINDELSE MED SPINOCEREBELLAR DEGENERATION
Int. application no.JP2015068438
Int. publication no.WO2016208045
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact